Tami Brutman‐Barazani

Author

Also Known As

T. Barazani‐Brutman, T. Brutman-Barazani, T. Brutman‐Barazani, Tamar Barazani Brutman, Tamar Brutman Barazani, Tamar Brutman-Barazani, Tamar Brutman‐Barazani, Tami B. Barazani, Tami Barazani-Brutman, Tami Barazani‐Brutman

Publications

767

Citations

H-Index

Concepts

All Affiliations

Sheba Medical Center Tel Aviv University Bar-Ilan University Sechenov University Weizmann Institute of Science

About

Tami Brutman‐Barazani is an author at Sheba Medical Center specializing in medicine, diabetes, and metabolic regulation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	167
2	Cell Biology	2	2	26
3	Cellular Physiology	2	2	26
4	Diabetes	2	2	69
5	Health Sciences	1	1	10

Tami Brutman‐Barazani

Publications

692

Citations

H-Index

Page 1

	Year	Citations
Emicizumab prophylaxis among infants and toddlers with severe hemophilia A and inhibitors—a single‐center cohort Assaf Arie Barg, Einat Avishai, Ivan Budnik, Pediatric Blood & Cancer	2019	92
Emicizumab treatment and monitoring in a paediatric cohort: real‐world data Assaf Arie Barg, Tami Livnat, Ivan Budnik, British Journal of Haematology	2020	78
Emicizumab prophylaxis: Prospective longitudinal real‐world follow‐up and monitoring Assaf A. Barg, Ivan Budnik, Einat Avishai, Haemophilia	2021	68
Sarcopoterium spinosum extract as an antidiabetic agent: In vitro and in vivo study Polina Smirin, Dvir Taler, Guila Abitbol, Journal of Ethnopharmacology Herbal MedicineNutraceutical IngredientDiabetesPharmacologyAntidiabetic Agent	2010	59
Subcutaneous Injection of Tranexamic Acid to Reduce Bleeding During Dermatologic Surgery: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial Isaac Zilinsky, Tami Brutman‐Barazani, Denis Visentin, Dermatologic Surgery	2019	57
Subcutaneous tranexamic acid in upper eyelid blepharoplasty: a prospective randomized pilot study Oded Sagiv, Elkanah Rosenfeld, Elinor Kalderon, Canadian Journal of Ophthalmology OphthalmologyOculoplasticsSubcutaneous Tranexamic AcidSurgeryGlaucoma	2018	55
Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab Sarina Levy‐Mendelovich, Tami Brutman‐Barazani, Ivan Budnik, Journal of Clinical Medicine	2021	40
Results of a phase I/II open‐label, safety and efficacy trial of coagulation factor IX (recombinant), albumin fusion protein in haemophilia B patients U. Martinowitz, Toshko Lissitchkov, Aaron Lubetsky, Haemophilia	2015	39
Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real‐world data Mudi Misgav, Tami Brutman‐Barazani, Ivan Budnik, Haemophilia	2021	37
Cytosolic Protein Tyrosine Phosphatase-ε Is a Negative Regulator of Insulin Signaling in Skeletal Muscle Shlomit Aga‐Mizrachi, Tami Brutman‐Barazani, Asia Bak, Endocrinology	2007	33

Page 1